Eoh Kyung Jin, Kim Yoo-Na, Nam Eun Ji, Kim Sang Wun, Kim Young Tae
Department of Obstetrics and Gynecology, Yongin Severance Hospital, Yonsei University College of Medicine, Yongin 16995, Republic of Korea.
Department of Obstetrics and Gynecology, Institute of Women's Medical Life Science, Yonsei Cancer Center, Severance Hospital, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722, Republic of Korea.
J Clin Med. 2023 Mar 1;12(5):1950. doi: 10.3390/jcm12051950.
In this study, we investigated the impact of uterine manipulation on endometrial cancer survival outcomes. We analyzed patients with endometrial cancer who underwent robot-assisted staging and open staging surgery between 2010 and 2020. Either uterine manipulators or vaginal tubes were utilized in robot-assisted staging. Propensity score matching was performed to correct baseline characteristics. Progression-free survival (PFS) and overall survival (OS) were analyzed using Kaplan-Meier curve analysis. In total, 574 patients, including those undergoing robot-assisted staging with a uterine manipulator ( = 213) or vaginal tube ( = 147) and staging laparotomy ( = 214), were analyzed. Propensity score matching was performed for age, histology, and stage as covariates. Before matching, Kaplan-Meier curve analysis showed that PFS and OS were significantly different among the three groups ( < 0.001 and = 0.009, respectively). In the propensity-matched cohorts of 147 women, the previously suggested differences in PFS and OS were not observed in patients undergoing robot-assisted staging with a uterine manipulator or vaginal tube or open surgery. In conclusion, robotic surgery using a uterine manipulator or vaginal tube did not compromise survival outcomes in endometrial cancer management.
在本研究中,我们调查了子宫操作对子宫内膜癌生存结局的影响。我们分析了2010年至2020年间接受机器人辅助分期和开放分期手术的子宫内膜癌患者。机器人辅助分期中使用了子宫操纵器或阴道管。进行倾向评分匹配以校正基线特征。使用Kaplan-Meier曲线分析来分析无进展生存期(PFS)和总生存期(OS)。总共分析了574例患者,包括使用子宫操纵器(n = 213)或阴道管(n = 147)进行机器人辅助分期以及分期剖腹手术(n = 214)的患者。以年龄、组织学和分期作为协变量进行倾向评分匹配。匹配前,Kaplan-Meier曲线分析显示三组之间的PFS和OS有显著差异(分别为P < 0.001和P = 0.009)。在147名女性的倾向评分匹配队列中,在使用子宫操纵器或阴道管进行机器人辅助分期或开放手术的患者中未观察到先前提示的PFS和OS差异。总之,使用子宫操纵器或阴道管的机器人手术在子宫内膜癌治疗中不会影响生存结局。